4 completed. 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow LDV: new trials by email Literature Review of LDV trials Research Report on LDV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1 Sofosbuvir, Ledipasvir, Ribavirin - Hepatitis C, Cirrhosis | Phase 3 | Completed | Tehran University of Medical Sciences | 50 | 2016-09-01 | 2018-04-30 |
| Measurement of Total Retinal Blood Flow During Flicker Stimulation in Healthy Subjects FDOCT, LDV, DVA - Healthy | Not applicable | Completed | Medical University of Vienna | 20 | 2015-10-01 | 2017-09-06 |
| Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions Telaprevir, Boceprevir, Sofosbuvir - Chronic Hepatitis C Infection | Completed | Valme University Hospital | 1128 | 2014-12-01 | 2022-06-29 | |
| Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3 SOF, RBV, PEG - Chronic Hepatitis C Infection | Phase 2 | Completed | Gilead Sciences | 292 | 2010-12-01 | 2014-11-17 |
Fibrosis (1) · Hemophilia A (1) · Hepatitis (1) · Hepatitis C (1)
Gilead Sciences (1) · Medical University of Vienna (1) · Tehran University of Medical Sciences (1) · Valme University Hospital (1)
Austria (1) · Iran (1) · New Zealand (1) · Spain (1)
Gerhard Garhoefer, MD (1) · Karin I Neukam, Dr (1) · Reza Malekzadeh, M.D. (1) · Robert H. Hyland, DPhil (1)
PMID 23281974, PMID 24262278, PMID 27409462, PMID 27415157, PMID 27882706, PMID 28004322, PMID 28137633, PMID 28599618, PMID 29377515, PMID 30853642, PMID 37671831